Home Newsfeeds Credit Suisse Maintains Outperform on Exelon, Raises Price Target to $46

Credit Suisse Maintains Outperform on Exelon, Raises Price Target to $46

Credit Suisse analyst Nicholas Campanella maintains Exelon (NASDAQ:EXC) with a Outperform and raises the price target from $42 to $46.

byBenzinga Newsdesk

January 23, 2023

1 minute read

Credit Suisse analyst Nicholas Campanella maintains Exelon (NASDAQ:EXC) with a Outperform and raises the price target from $42 to $46.

News
Tech

Fast And Ford-ious: Dwayne Johnson Adds F-150 Raptor R To His Collection In Jim Farley’s Presence

By Anan Ashraf

August 15, 7:07 AM

Actor Dwayne Johnson, aka the Rock, has gotten himself a new Ford (NYSE: F) off-road pickup truck in the presence of company CEO Jim Farley.

Gold Moves Lower; ISM Services PMI Beats Estimates

By Avi Kapoor

February 5, 1:08 PM

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday. The Dow traded down 1.04% to 38,253.72 while the NASDAQ fell 0.86% to 15,493.97. The S&P 500 also fell, dropping, 0.70% to 4,923.81.

CHEA

Here’s How Much You Would Have Made Owning Photronics Stock In The Last 5 Years

By Benzinga Insights

August 31, 11:16 AM

Photronics (NASDAQ:PLAB) has outperformed the market over the past 5 years by 6.43% on an annualized basis producing an average annual return of 16.57%. Currently, Photronics has a market capitalization of $1.03 billion.

PLAB

ClearPoint Neuro Congratulates Its Partner AviadoBio On First Patient Treated In Its ASPIRE-FTD Clinical Trial Evaluating AVB-101 For Frontotemporal Dementia With GRN Mutations

By Benzinga Newsdesk

April 16, 4:23 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its

CLPT

Credit Suisse Maintains Outperform on Exelon, Raises Price Target to $46

Related Posts

Fast And Ford-ious: Dwayne Johnson Adds F-150 Raptor R To His Collection In Jim Farley’s Presence

Gold Moves Lower; ISM Services PMI Beats Estimates

Here’s How Much You Would Have Made Owning Photronics Stock In The Last 5 Years

ClearPoint Neuro Congratulates Its Partner AviadoBio On First Patient Treated In Its ASPIRE-FTD Clinical Trial Evaluating AVB-101 For Frontotemporal Dementia With GRN Mutations